Clinical Trial Update: L-Arginine Role for Stone Lower Ureter : A Randomized Control Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial evaluating the role of L-Arginine for lower ureteral stones has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureterolithiasis

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Sohag University | Conditions: Stone Lower Ureter | Phase 4 | Status: COMPLETED